NASDAQ: YS Investor Notice: Investigation over Potential Wrongdoing at YS Biopharma Co., Ltd.
An investigation on behalf of investors in YS Biopharma Co., Ltd. (NASDAQ: YS) shares over potential wrongdoing at YS Biopharma Co., Ltd. was announced.
San Diego, CA -- (SBWire) -- 06/19/2023 --Certain directors of YS Biopharma Co., Ltd. are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of YS Biopharma Co., Ltd. (NASDAQ: YS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain YS Biopharma Co., Ltd. directors breached their fiduciary duties and caused damage to the company and its shareholders.
China based YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. YS Biopharma Co., Ltd. reported that its Total Revenue rose from $257.01 million for the 12 months that ended on March 31, 2021, to $502.95 million for the 12 months period that ended on March 31, 2022, and that its Net Loss over those respective time periods declined from $191.82 million to $106 million.
Shares of YS Biopharma Co., Ltd. (NASDAQ: YS) declined from $18.44 per share on March 15, 2023, to as low as $1.24 per share on June 12, 2023.
Those who purchased shares of YS Biopharma Co., Ltd. (NASDAQ: YS) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Media Relations Contact
Michael Daniels
Shareholders Foundation, Inc.
+1-(858)-779-1554
http://www.ShareholdersFoundation.com
View this press release online at: http://rwire.com/1375088